Nuclear fragmentation cross sections for therapy beams

48

No. 787 in all physics · No. 37 in Medical and Radiation Physics

Non-expert version

Measure and model partial charge-changing and isotopic production cross sections for projectiles of Z from 2 to 10 at 100 to 450 MeV per nucleon on hydrogen, carbon, nitrogen, oxygen and calcium targets, to about 5 percent, including fragment angular and energy distributions. An answer is a cross-section set that lets Monte Carlo transport reproduce measured depth-dose tails to within 1 percent of peak dose.

What would settle it

Thin-target fragmentation experiments covering the therapeutic energy range, benchmarked against measured depth-dose and lateral profiles.

Status in the literature

Unverified note: it names recent work and was partly written without a live literature search; it awaits a check by an editor.

Dedicated campaigns since about 2020 have filled gaps, yet model spread in the fragment tail remained several percent in 2025.

No solutions, ideas or subproblems yet.

How results are checked

See also

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.

Details, signature and history
Kind
Well-posed question
Answer
Value
Posed
1990
Topic review
Paganetti, Relative biological effectiveness (RBE) values for proton beam therapy: variations as a function of biological endpoint, dose, and linear energy transfer, Physics in Medicine and Biology, 2014. Link
Record
Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor

Proof

Fingerprint
1d9f1a7d04e8…
Public log
Entry 1,689, in checkpoint 2,123
In the log by
Block 969,698, 2026-10-03

This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.

History